Antibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations
- Western blot [2]
- ELISA [1]
- Immunoprecipitation [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN565191 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Breast Cancer Metastasis Suppressor 1 (BRMS1) (AA 1-246), (full length) antibody
- Antibody type
- Monoclonal
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 1-246, full length
- Isotype
- IgG
- Antibody clone number
- 2D4-2G11
- Vial size
- 100 μg
- Storage
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
- Handling
- Aliquot to avoid repeated freezing and thawing.
Submitted references Expression of the metastasis suppressor BRMS1 in uveal melanoma.
BRMS1 suppresses lung cancer metastases through an E3 ligase function on histone acetyltransferase p300.
Low BRMS1 expression promotes nasopharyngeal carcinoma metastasis in vitro and in vivo and is associated with poor patient survival.
Breast cancer metastasis suppressor 1 (BRMS1) is destabilized by the Cul3-SPOP E3 ubiquitin ligase complex.
BRMS1 transcriptional repression correlates with CpG island methylation and advanced pathological stage in non-small cell lung cancer.
Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis and correlates with improved patient survival in non-small cell lung cancer.
Proteomics-based strategy to delineate the molecular mechanisms of the metastasis suppressor gene BRMS1.
Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis.
Ventura BV, Quezada C, Maloney SC, Fernandes BF, Antecka E, Martins C, Bakalian S, di Cesare S, Burnier MN Jr
Ecancermedicalscience 2014;8:410
Ecancermedicalscience 2014;8:410
BRMS1 suppresses lung cancer metastases through an E3 ligase function on histone acetyltransferase p300.
Liu Y, Mayo MW, Nagji AS, Hall EH, Shock LS, Xiao A, Stelow EB, Jones DR
Cancer research 2013 Feb 15;73(4):1308-17
Cancer research 2013 Feb 15;73(4):1308-17
Low BRMS1 expression promotes nasopharyngeal carcinoma metastasis in vitro and in vivo and is associated with poor patient survival.
Cui RX, Liu N, He QM, Li WF, Huang BJ, Sun Y, Tang LL, Chen M, Jiang N, Chen L, Yun JP, Zeng J, Guo Y, Wang HY, Ma J
BMC cancer 2012 Aug 29;12:376
BMC cancer 2012 Aug 29;12:376
Breast cancer metastasis suppressor 1 (BRMS1) is destabilized by the Cul3-SPOP E3 ubiquitin ligase complex.
Kim B, Nam HJ, Pyo KE, Jang MJ, Kim IS, Kim D, Boo K, Lee SH, Yoon JB, Baek SH, Kim JH
Biochemical and biophysical research communications 2011 Dec 2;415(4):720-6
Biochemical and biophysical research communications 2011 Dec 2;415(4):720-6
BRMS1 transcriptional repression correlates with CpG island methylation and advanced pathological stage in non-small cell lung cancer.
Nagji AS, Liu Y, Stelow EB, Stukenborg GJ, Jones DR
The Journal of pathology 2010 Jun;221(2):229-37
The Journal of pathology 2010 Jun;221(2):229-37
Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis and correlates with improved patient survival in non-small cell lung cancer.
Smith PW, Liu Y, Siefert SA, Moskaluk CA, Petroni GR, Jones DR
Cancer letters 2009 Apr 18;276(2):196-203
Cancer letters 2009 Apr 18;276(2):196-203
Proteomics-based strategy to delineate the molecular mechanisms of the metastasis suppressor gene BRMS1.
Rivera J, Megias D, Bravo J
Journal of proteome research 2007 Oct;6(10):4006-18
Journal of proteome research 2007 Oct;6(10):4006-18
Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis.
Liu Y, Smith PW, Jones DR
Molecular and cellular biology 2006 Dec;26(23):8683-96
Molecular and cellular biology 2006 Dec;26(23):8683-96
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- ELISA
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IP